Dr. Megan S. Wheelden, MD

Dr. Wheelden practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Wheelden's NPI, 1245677301, was assigned on May 30, 2013. Dr. Wheelden holds Pennsylvania license MT212539.

Dr. Wheelden's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Dr. Wheelden's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. Dr. Wheelden is also affiliated with WellSpan Chambersburg Hospital. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Wheelden to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wheelden practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wheelden's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Wheelden's licenses on file in 2 states: Pennsylvania and Rhode Island.

CMS data shows 380 Medicare services from Dr. Wheelden across 6 procedure codes in 2024, for 138 Medicare patients. Medicare paid $29,666 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 138 Medicare patients who saw Dr. Wheelden in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wheelden's median patient age at 73, with 21% women.

In 2024, Dr. Wheelden wrote 993 Medicare Part D claims for 96 patients. 80% of them were for generic drugs. CMS names the drug for 795 of them, across 22 drugs with 11 or more claims each, at $1,323,606 in total drug cost. In 2023, CMS named 898 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Wheelden for performance year 2024, reported as part of a group. Dr. Wheelden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wheelden as offering telehealth.

Dmand AI links 5 papers to Dr. Wheelden, published from 2018 to 2023. Dr. Wheelden's most frequent co-authors are Monika Joshi, MD, Priyanka Bhatia, MD and Joseph J. Drabick, MD.

CMS Open Payments shows 25 general payments to Dr. Wheelden from 10 drug and device companies from 2018 to 2025. Honoraria make up the largest share, 39% of the total. Exelixis Inc. paid the most, $3,651.